Skip to content

Clinical trials

Phase 2 Connective Tissue Diseases trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Connective Tissue Diseases Phase: Phase 2 Country / region: Germany Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20181
20192
20211
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated3
Active, not recruiting2
Completed2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alumis Inc1
Amgen1
Beeline Medicines Corporation1
Liquidia Technologies, Inc.1
Novartis Pharmaceuticals1
Ultragenyx Pharmaceutical Inc1
Viatris Innovation GmbH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Connective Tissue Diseases7
Immune System Diseases4
Autoimmune Diseases3
Lupus Erythematosus, Systemic3
Arthritis1
Dry Eye Syndromes1
Eye Diseases1
Familial Primary Pulmonary Hypertension1
Fractures, Bone1
Hypertension, Pulmonary1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.